IRETIG 50mg prolonged tablets medication leaflet

G04BD12 mirabegron • Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence

Mirabegronum is a medication used for the treatment of overactive bladder, characterized by symptoms such as frequent urination, urinary urgency, and urinary incontinence. It acts as a beta-3 adrenergic receptor agonist, relaxing the bladder muscles and increasing its capacity.

The medication is taken orally, usually once daily, and is effective in reducing symptoms associated with overactive bladder.

Side effects may include high blood pressure, urinary tract infections, headache, and nausea. It is important to monitor blood pressure during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Mirabegronum. Follow the prescribed dosage and adhere to all medical recommendations.

General data about IRETIG 50mg

Substance: mirabegron

Date of last drug list: 01-12-2024

Commercial code: W70723003

Concentration: 50mg

Pharmaceutical form: prolonged tablets

Quantity: 100

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA

Holder: ZENTIVA, K.S. - REPUBLICA CEHA

Number: 15686/2024/03

Shelf life: 2 years

Concentrations available for mirabegron

25mg, 50mg